EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Ameliorative Effects of D-Ribose-L-Cysteine on Hematological Indices and Metabolic Intermediates in Diabetic Male Wistar Rats

Happy Isibor, Anthony Taghogho Eduviere, Benneth Ben-Azu, Celestine Ogheneruro Akpovwre

Emerging Frontiers in Translational Biomedicine and Health Sciences · 20.12.2025 · 1 (2) · 61-71

DOI: 10.66779/9tth4b51 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Emerging Frontiers in Translational Biomedicine and Health Sciences, online erschienen am 20.12.2025. Verfasst von Happy Isibor und 3 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2DM) is a chronic disorder characterized by hyperglycemia, insulin resistance, oxidative stress, and progressive β-cell dysfunction. Hematological parameters and metabolic intermediates often reflect systemic inflammation, immune competence, mitochondrial activity, and redox balance, all of which are perturbed in diabetes. This study evaluated the effects of D-ribose-L-cysteine (DRLC), a glutathione precursor, on hematological indices and selected intermediates of energy metabolism in male Wistar rats exposed to a High-Fat Diet (HFD) and Streptozotocin (STZ) (HFD+STZ).

Methods

Animals were randomly divided into control, HFD+STZ, HFD+STZ+DRLC (150 and 300 mg/kg), and HFD+STZ+metformin (100 mg/kg) groups. Treatments were administered orally for 28 days. Hematological indices (White Blood Cells (WBC), Lymphocytes (LYM), Hemoglobin (Hb), Red Blood Cells (RBCs), Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin Concentration (MCHC), and metabolic intermediates (pyruvate, succinate, lactate) together with Malate Dehydrogenase (MDH) activity were assessed.

Results

The HFD+STZ group developed significant leukocytosis, lymphocytosis, anemia, elevated MCV, reduced pyruvate and succinate, increased lactate levels, and altered MDH activity compared to controls (p

Zitieren

APA

Isibor, H., Eduviere, A. T., Ben-Azu, B., & Akpovwre, C. O. (2025). Ameliorative Effects of D-Ribose-L-Cysteine on Hematological Indices and Metabolic Intermediates in Diabetic Male Wistar Rats. Emerging Frontiers in Translational Biomedicine and Health Sciences, 1(2), 61-71. https://doi.org/10.66779/9tth4b51

Vancouver

Isibor H, Eduviere AT, Ben-Azu B, Akpovwre CO. Ameliorative Effects of D-Ribose-L-Cysteine on Hematological Indices and Metabolic Intermediates in Diabetic Male Wistar Rats. Emerging Frontiers in Translational Biomedicine and Health Sciences. 2025;1(2):61-71. doi:10.66779/9tth4b51

BibTeX
@article{Isibor2025,
  author = {Isibor, Happy and Eduviere, Anthony Taghogho and Ben-Azu, Benneth and Akpovwre, Celestine Ogheneruro},
  title = {Ameliorative Effects of D-Ribose-L-Cysteine on Hematological Indices and Metabolic Intermediates in Diabetic Male Wistar Rats},
  journal = {Emerging Frontiers in Translational Biomedicine and Health Sciences},
  year = {2025},
  volume = {1},
  number = {2},
  pages = {61--71},
  doi = {10.66779/9tth4b51}
}
Kostenlos starten →